U.S. grownup weight problems price fell in 2023, as use of GLP-1 meds rose
The U.S. weight problems price declined for the primary time in a…
Greater than half of US adults may benefit from GLP-1 drugs, researchers discover
Semaglutide Eligibility Amongst US Adults. Credit score: JAMA Cardiology (2024). DOI: 10.1001/jamacardio.2024.4657…
GLP-1 RA use tied to decrease charge of venous thromboembolism in diabetes
For sufferers with kind 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor…
